Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Stockholders' Equity

v3.20.2
Condensed Statements of Stockholders' Equity - USD ($)
Class A Preferred Stock [Member]
Class A Common Shares [Member]
Common Shares [Member]
Common Stock Issuable
Additional Paid-in Capital
Accumulated Deficit
Total
Balances at Dec. 31, 2018     $ 3,000 $ 2,085,000 $ 113,378,000 $ (79,070,000) $ 36,396,000
Balances (in shares) at Dec. 31, 2018 250,000 1,000,000 26,610,183        
Issuance of common shares - Founders Agreement       (2,085,000) 2,085,000    
Issuance of common shares - Founders Agreement (in shares)     709,314        
Issuance of common shares - Equity fee on Horizon Notes to Fortress Biotech         375,000   375,000
Issuance of common shares - Equity fee on Horizon Notes to Fortress Biotech (in shares)     108,069        
Issuance of warrants - Horizon Notes         888,000   888,000
Conversion of Class A common shares to common shares (in shares)   (137,608) 137,608        
Issuance of common shares, net of offering costs - At-the-Market Offering         21,972,000   21,972,000
Issuance of common shares, net of offering costs - At-the-Market Offering (in Shares)     3,506,222        
Issuance of common shares - Equity fee on At-the-Market Offering         $ 495,000   $ 495,000
Issuance of common shares - Equity fee on At-the-Market Offering (in shares)     87,656        
Issuance of common shares, value     $ 7,906,250        
Issuance of common shares (in shares)     1,000   29,484,000   29,485,000
Issuance of common shares - Equity fee on Public Offering         $ 791,000   $ 791,000
Issuance of common shares - Equity fee on Public Offering (in shares)     197,656        
Stock-based compensation expenses         1,054,000   1,054,000
Stock-based compensation expenses (in shares)     126,000        
Exercise of warrants (in shares)     65,358        
Net loss           (20,012,000) (20,012,000)
Balances at Jun. 30, 2019     $ 4,000   170,522,000 (99,082,000) 71,444,000
Balances (in shares) at Jun. 30, 2019 250,000 862,392 39,454,316        
Balances at Mar. 31, 2019     $ 3,000   117,158,000 (88,683,000) 28,478,000
Balances (in shares) at Mar. 31, 2019 250,000 1,000,000 27,561,433        
Conversion of Class A common shares to common shares (in shares)   (137,608) 137,608        
Issuance of common shares, net of offering costs - At-the-Market Offering         21,972,000   21,972,000
Issuance of common shares, net of offering costs - At-the-Market Offering (in Shares)     3,506,222        
Issuance of common shares - Equity fee on At-the-Market Offering         $ 495,000   $ 495,000
Issuance of common shares - Equity fee on At-the-Market Offering (in shares)     87,656        
Issuance of common shares, value     $ 7,906,250        
Issuance of common shares (in shares)     1,000   29,484,000   29,485,000
Issuance of common shares - Equity fee on Public Offering         $ 791,000   $ 791,000
Issuance of common shares - Equity fee on Public Offering (in shares)     197,656        
Stock-based compensation expenses         622,000   622,000
Stock-based compensation expenses (in shares)     50,000        
Exercise of warrants (in shares)     7,491        
Net loss           (10,399,000) (10,399,000)
Balances at Jun. 30, 2019     $ 4,000   170,522,000 (99,082,000) 71,444,000
Balances (in shares) at Jun. 30, 2019 250,000 862,392 39,454,316        
Balances at Dec. 31, 2019 $ 0 $ 0 $ 4,000 4,923,000 172,184,000 (125,459,000) 51,652,000
Balances (in shares) at Dec. 31, 2019 250,000 845,385 39,403,519        
Balances at Mar. 31, 2020     $ 4,000   183,116,000 (137,316,000) 45,804,000
Balances (in shares) at Mar. 31, 2020 250,000 845,385 42,076,840        
Balances at Dec. 31, 2019 $ 0 $ 0 $ 4,000 4,923,000 172,184,000 (125,459,000) 51,652,000
Balances (in shares) at Dec. 31, 2019 250,000 845,385 39,403,519        
Issuance of common shares - Founders Agreement       (4,923,000) 4,923,000    
Issuance of common shares - Founders Agreement (in shares) 0 0 1,206,667        
Issuance of common shares, net of offering costs - At-the-Market Offering         7,843,000   7,843,000
Issuance of common shares, net of offering costs - At-the-Market Offering (in Shares)     2,135,634        
Issuance of common shares - Equity fee on At-the-Market Offering         202,000   202,000
Issuance of common shares - Equity fee on At-the-Market Offering (in shares)     53,390        
Issuance of common shares, value     $ 1,000   34,923,000   34,924,000
Issuance of common shares (in shares)     11,455,604        
Issuance of common shares - Equity fee on Public Offering         932,000   932,000
Issuance of common shares - Equity fee on Public Offering (in shares)     286,390        
Issuance of common shares under ESPP         169,000   $ 169,000
Issuance of common shares under ESPP (in shares)     68,351       68,351
Stock-based compensation expenses         1,762,000   $ 1,762,000
Stock-based compensation expenses (in shares)     213,689        
Exercise of warrants (in shares)     2,999        
Net loss           (26,455,000) (26,455,000)
Balances at Jun. 30, 2020     $ 5,000 0 222,938,000 (151,914,000) 71,029,000
Balances (in shares) at Jun. 30, 2020 250,000 845,385 54,826,243        
Balances at Mar. 31, 2020     $ 4,000   183,116,000 (137,316,000) 45,804,000
Balances (in shares) at Mar. 31, 2020 250,000 845,385 42,076,840        
Issuance of common shares, net of offering costs - At-the-Market Offering         77,000   77,000
Issuance of common shares, net of offering costs - At-the-Market Offering (in Shares)     22,170        
Issuance of common shares - Equity fee on At-the-Market Offering         2,933,000   2,933,000
Issuance of common shares - Equity fee on At-the-Market Offering (in shares)     886,800        
Issuance of common shares, value         932,000   932,000
Issuance of common shares (in shares)     286,390        
Issuance of common shares under ESPP     $ 1,000   34,923,000   $ 34,924,000
Issuance of common shares under ESPP (in shares)     11,455,604       68,351
Stock-based compensation expenses         957,000   $ 957,000
Stock-based compensation expenses (in shares)     98,439        
Net loss           (14,598,000) (14,598,000)
Balances at Jun. 30, 2020     $ 5,000 $ 0 $ 222,938,000 $ (151,914,000) $ 71,029,000
Balances (in shares) at Jun. 30, 2020 250,000 845,385 54,826,243